Page 4 - நிறுவனம் ஆஃப் வெப்பமண்டல மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kyoto University The Haruhisa Inoue lab uses iPS cells to find potential drugs against RNA viruses. The last year has seen intensive research around the world on SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite several vaccines already available, the rapid mutation of the virus is causing concern that the infection will continue to spread. A new study led by CiRA Professor Haruhisa Inoue shows that iPS cells can assist in finding effective drugs for RNA viruses. HIV, Ebola virus, and now the SARS-CoV-2 pandemic, in the last half century, RNA viruses have been responsible for many of society’s greatest health calamities. One of the great challenges in managing these viruses is their rapid mutation rate. Indeed, it is possible that as SARS-Cov-2 continues to mutate, it may need, like influenza, new vaccines annually.

Sayaka okadaGreifswald insel riemsHaruhisa inoueKeiko imamuraJitsutaro kawaguchiKyohei nishiThomas hoenenAkira ohtaYasuteru sakuraiJiro yasudaTsugumine shuPs cells teamBioresource research centerInstitute of molecular virologyNagasaki universityNational research center